The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Arcutis Biotherapeutics, Inc(NASDAQ:ARQT) 
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atop...
Website: http://www.arcutis.com
Founded: 2016
Full Time Employees: 53
CEO: Todd Franklin Watanabe
Sector: Healthcare
Industry: Biotechnology
Arcutis Biotherapeutics Number of Twitter Followers
Arcutis Biotherapeutics Days Payable Outstanding ttm (DPO)
Arcutis Biotherapeutics Days Receivable Outstanding ttm (DSO)
Arcutis Biotherapeutics Days Inventory Outstanding ttm (DIO)
Arcutis Biotherapeutics Op Cashflow Per Share ttm
Arcutis Biotherapeutics Free Cashflow Per Share ttm
Arcutis Biotherapeutics Cash Per Share ttm
Arcutis Biotherapeutics P/S ratio ttm
Arcutis Biotherapeutics (GAAP) P/E ratio ttm
Arcutis Biotherapeutics P/B ratio ttm
No extra charts and metrics for this ticker.